$Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment$

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment

We aimed to identify the characteristics of immune reconstitution (IR) in patients who recovered from steroid-refractory acute graft-versus-host disease (SR-aGVHD) after basiliximab treatment. A total of 179, 124, 80, and 92 patients were included in the analysis for IR at 3, 6, 9, and 12 months, re...

Full description

Bibliographic Details
Main Authors:	Dao-Xing Deng, Shuang Fan, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Xu-Ying Pei, Ying-Jun Chang, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Oncology
Subjects:	Immune reconstitution basiliximab steroid-refractory acute graft-versus-host disease haploidentical allogeneic hematopoietic stem cell transplantation
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.916442/full

Similar Items

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment
by: Cong Cheng, et al.
Published: (2024-03-01)

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
by: Zhenli Huang, et al.
Published: (2022-11-01)

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-03-01)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01)

Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature
by: Donglin Yang, et al.
Published: (2023-12-01)

Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial
by: Yu Wang, et al.
Published: (2022-04-01)

Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
by: Huidong Guo, et al.
Published: (2024-10-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
by: Haixia Fu, et al.
Published: (2024-02-01)

Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment
by: Chen‐hua Yan, et al.
Published: (2022-12-01)

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease
by: Zicheng Gao, et al.
Published: (2024-07-01)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
by: Naohiro Ijiri, et al.
Published: (2022-09-01)

Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
by: Wenshuai Zheng, et al.
Published: (2022-12-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

EXPERIÊNCIA COM USO DE BASILIXIMAB (SIMULECT®) EM UM ÚNICO SERVIÇO DE TRANSPLANTE RENAL
by: Tereza Matuck, et al.
Published: (2005-01-01)

Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
by: XiaoYan Yue, et al.
Published: (2024-02-01)

Basiliximab vs. Antithymocyte Globulin as Initial Induction Therapy for Lung Transplantation: A National Two Years Review
by: Bruno Mendes, et al.
Published: (2022-08-01)

Clinical-economic impact of the change of protocol for use of basiliximab in liver transplant
by: Enrique Tévar-Alfonso, et al.
Published: (2019-01-01)

Haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood in hematologic malignancy patients: A report of 80 cases
by: Cong Zeng, et al.
Published: (2022-09-01)

Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report
by: Yili Fan, et al.
Published: (2023-12-01)

Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report
by: Tingting Chen, et al.
Published: (2022-09-01)

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
by: Samuel Cytryn, et al.
Published: (2020-04-01)

PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study
by: Xin-Yu Zhuang, et al.
Published: (2022-11-01)

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
by: Junbin Huang, et al.
Published: (2023-02-01)

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
by: Ke Zhao, et al.
Published: (2022-03-01)

Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia
by: Yu-Xin Wang, et al.
Published: (2024-08-01)

Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy
by: Wen-Jing Yu, et al.
Published: (2024-12-01)

Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation
by: Zhou Z, et al.
Published: (2023-07-01)

Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children’s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study
by: Yongsheng Ruan, et al.
Published: (2022-10-01)

Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis
by: Muhammad Umair Mushtaq, et al.
Published: (2022-10-01)

Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia
by: Fang Hua, et al.
Published: (2024-12-01)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
by: Masashi Furukawa, et al.
Published: (2022-06-01)

Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
by: Lan-Ping Xu, et al.
Published: (2019-09-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
by: Ying Yang, et al.
Published: (2022-09-01)

Comparación del rechazo agudo durante el primer año del injerto en pacientes transplantados renales que recibieron Basiliximab o Daclizumab, en el Hospital Calderón Guardia, durante el período 2000-2008
by: Jorge Andrés Umaña González, et al.
Published: (2011-08-01)

Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy
by: Ahmed Gaballa, et al.
Published: (2022-08-01)

Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis
by: Hengwei Wu, et al.
Published: (2023-05-01)

Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
by: Shuang Fan, et al.
Published: (2022-08-01)